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2214-0247/Copyright ª 2014, TaiwanAbstract Hypoxia-inducible factor-1a (HIF-1a) is important for placental development. This
study aims to determine whether the increased level and expression of HIF could be used to
demonstrate failed placentation in women with preeclampsia. The study included 20 pregnant
females [10 with and 10 without preeclampsia (the control group)]. Placental tissues were
collected and stained with hematoxylin and eosin. Immunohistochemical studies for evaluating
the expression of HIF-1a by these tissues were then performed. The results demonstrated that
placental tissues collected from mothers with preeclampsia showed a variety of histomorpho-
logical changes. All the cytotrophoblasts rimming the placental villi in mothers with pre-
eclampsia demonstrated a strong and uniform nuclear staining with HIF-1a. The study
results indicated that cytotrophoblasts respond to an ischemic environment by their nuclear
expression of HIF-1a, and thus we conclude that this transcription factor has a significant po-
tential as a marker for preeclampsia.
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122 M. Akhilesh et al.IntroductionPreeclampsia is a pregnancy-specific disorder. At present,
the definition of this disorder is solely based on physical
signs such as hypertension and proteinuria,1,2 and its eti-
ology needs further investigation. Therefore, preeclampsia
is defined as pregnancy-induced hypertension and protein-
uria. According to the American College of Obstetricians
and Gynecologists guidelines, preeclampsia occurs in 3e5%
of pregnant women worldwide and normally manifests
during the 20th week of gestation.3
Placentation is a process of molecular mimicry or
pseudo-vasculogenesis, in which the trophoblasts acquire
an endovascular phenotype and invade the uteroplacental
spiral arteries.4 The arteries, which are initially elastic and
of small caliber, are converted into inelastic and dilated
tubes, devoid of maternal vasomotor control. This physio-
logical remodeling provides optimal perfusion and oxygen
supply for maintenance of pregnancy. More specifically, the
uteroplacental arteries lose their musculature and enlarge
up to four to six times the diameter of the same vessel in
nonpregnant women.5,6
The process of placentation is known to be aberrant in
women with preeclampsia. In this case, the cytotropho-
blasts fail to adopt the invasive endothelial phenotype that
is necessary for normal physiological remodeling.7,8
Therefore, the uteroplacental spiral arteries remain only
as small-caliber elastic vessels. This is failed, abnormal, or
aberrant pseudovasculogenesis. As a result, there is
reduced blood flow to the placenta, which results in
placental ischemia or hypoxic placenta. A hypoxic placenta
then releases numerous vasoactive factors such as tyrosine
kinase-1, tumor necrosis factor 1-a, and interleukin-6 that
cause a decrease in nitric oxide bioavailability and an in-
crease in reactive oxygen species. A combination of these
two events results in an increase in total peripheral resis-
tance and manifests as hypertension.9
A hypoxic placenta causes accumulation of placenta-
generated soluble factors. There can be a mixed conse-
quence to this depending on the effects of the factors
produced. Potent angiogenic factors that play an impor-
tant role in the stimulation of blood vessel growth, such as
vascular endothelial growth factor (VEGF), soluble fms-
like tyrosine kinase 1 (sFlt1), and placental growth factor
have been suggested to be present in preeclamptic
placentae.10 Another placenta-soluble substance released
is hypoxia-inducible factor 1a (HIF-1a), and its effects,
expression, and regulation have been evaluated
previously.11,12
HIF consists of two members of the basic helix-
eloopehelixehelix transcription factor family, namely,
HIF-1a and HIF-1b. The HIF-1a is a short-lived protein and is
the transcription factor for a large number of genes. It is
known to mediate the delivery of oxygen and other nutri-
ents through the induction of angiogenesis.13,14 HIF-1a
binds to hypoxia-response elements in promoting the ac-
tivity of many genes involved in the adaptation to an
environment of insufficient oxygen supply (hypoxia). It is a
major regulator of cell function and differentiation, and
mediates the effects of oxygen on human trophoblast
development.12,14 On the downside, however, HIF-1a isknown to activate the transcription factor of VEGF and
promotes tumor cells to survive under hypoxic conditions,
as VEGF is a key factor in tumor angiogenesis.13e15
Results of previous studies have demonstrated the
presence of HIF-1a in preeclamptic placentae.16 HIF-1a has
also been shown to be strongly expressed from the 5th week
of gestation onward, especially in the syncytiotrophoblast,
villous cytotrophoblast, and extravillous trophoblast.11 The
increase in the levels of HIF-1a is closely related to the
increase in the levels of another protein called telomerase
or hTERT. Further studies have identified that the placental
production of HIF-1a mediates the increase in the levels of
telomerase during hypoxia, which plays a role in the mod-
ulation and proliferation of trophoblasts.14,15 However,
whether the increase in levels of this protein occurs in
parallel with severe aberrant pseudovasculogenesis re-
quires further investigation.
This pilot study aimed to identify the histological and
immunohistochemical differences in placental pseudo-
vasculogenesis by performing a biopsy on the placentae of
mothers with and without preeclampsia. It also aimed to
demonstrate staining patterns of HIF-1a and investigated
whether the transcription factor HIF-1a can function as a
marker for preeclampsia.Materials and methods
This is a caseecontrol pilot study. All of the 20 pregnant
mothers in this study provided their consent for participa-
tion and their placental tissue was harvested. Feasibility of
this study was discussed with the Department of Obstetrics
and Gynaecology (Ampang Hospital, Kuala Lumpur,
Malaysia). Mothers were identified and recruited by co-
investigators from the Ampang Hospital. Patients’ particu-
lars and clinical data including their name, age, date of
admission, para, gravida, blood group, blood pressure, and
urine protein levels were recorded subsequent to obtaining
informed and written consent.
This study was conducted according to the guidelines
stated in the Declaration of Helsinki. The study protocol
was approved by the Institutional Ethics Committee.
Inclusion criteria were as follows: mothers who were
newly diagnosed cases of preeclampsia and who were not
more than 45 years of age, pregnant mothers with systolic
blood pressure more than 140 mmHg and diastolic blood
pressure more than 90 mm Hg, and 24-hour urine protein
levels in the nephrotic range at diagnosis. Only consenting
mothers were recruited for the study.
Exclusion criteria were patients with other comorbidities
such as diabetes mellitus and essential hypertension in an
effort to preclude morphological effects of these conditions
on blood vessels inclusive of uteroplacental spiral arteri-
oles. Nonconsenting patients were excluded from the study.
Because this is a preliminary study, the sample size was
limited to 20 cases, and a biopsy of the placentae of all
participants was performed. The patients were divided into
two experimental groups, namely, Group 1 and Group 2.
Experimental Group 1 consisted of 10 pregnant mothers
with newly diagnosed preeclampsia without comorbidities.
Experimental Group 2 consisted of 10 pregnant mothers
without comorbidities.
Hypoxia-inducible factor and placental ischemia 123Placental tissue was collected from mothers delivering
vaginally as well as by cesarean section. The technique of
grossing of the placental tissue was restricted to 4-mm-
thick, flat, shaved sections of the basal plate of the
placenta. The tissues were embedded en face in anticipa-
tion of demonstration of increased numbers of spiral arte-
rioles as compared with traditional full-thickness
longitudinal sections of placenta. It was presumed that
using en face shaved sections of the placental base exposed
more surface area of the bed in proximity to the opposing
myometrium, indirectly increasing a view of the
fetoematernal interface blood vessels. Randomly shaved
en face sections (approximately 4-mm thick) of the basal
plate of the placenta were taken, sealed into labeled cas-
settes (histosettes), and fixed in formalin for about 3 weeks
prior to processing. Sections were stained with hematoxylin
and eosin and immunohistochemical marker HIF-1a. The
placental sections were studied to document and grade
features of placental ischemia in mothers with pre-
eclampsia. Spiral arterioles were identified and patterns of
staining were documented and analyzed. The immunohis-
tochemical staining patterns were noted and the staining
intensity (from 1þ to 3þ) and location were identified. The
histology study results of the placenta from normal mothers
were used for comparison.
Results
Mothers with preeclampsia were aged between 20 years
and 35 years with uterine fundal heights ranging between
29 weeks and 34 weeks. The placental weights in normal
mothers were greater when compared with the pre-
eclamptic mothers. Shaved sections of the placental floor
demonstrated an average of four spiral blood vessels per
case.
Placental tissues from normal pregnant mothers
demonstrated the presence of a uniform, small population
of well-vascularized third trimester placental villi collared
by cytotrophoblasts. Syncytiotrophoblasts were noted to be
normal in number and their distribution and syncytial knots
were not significantly increased. Placental floor infarcts
were not recognized and fibrin intervals were scanty.
Atherosis was not demonstrated (Fig. 1A). However,Figure 1 (A) A normal third trimester placenta. Uniform, small, a
and syncytiotrophoblasts. The syncytiotrophoblasts are normal; no
three spiral arterioles. The walls display a significant degree of fibr
eosin, 200).fractured amorphous calcifications were evident in a few
cases consistent with an aging placenta.
Placentae from mothers with preeclampsia showed a
variety of histomorphological changes. The placental villi
were of varying sizes (geographic villi) and exhibited
significantly increased numbers of syncytial knots. Several
sclerotic villi were noted. Significant amounts of inter-
villous fibrin were seen to entrap sclerotic placental villi.
Chorangiosis was a consistent feature of ischemic changes
in placentae of mothers with preeclampsia (Fig. 1B).
Atherosis was not a consistent feature of all placentae from
mothers with preeclampsia, whereas infarcts of the
placental floor were a consistent feature. Chunky, amor-
phous, fractured calcifications were also noted.
The histomorphological features of placental ischemia
were corroborated with the staining patterns of immuno-
histochemical marker. The HIF-1a immunohistochemical
staining was performed on both normal and preeclamptic
placentae. It was found that the cytotrophoblasts rimming
the placental villi in normal mothers did not reflect a nu-
clear uptake of the HIF-1a stain. By contrast, all the cyto-
trophoblasts rimming the placental villi in mothers with
preeclampsia demonstrated a strong and uniform nuclear
staining with HIF-1a. Positive staining was not appreciated
in the cells lining the spiral arterioles in a significant
manner (Fig. 2).
Discussion
This study evaluated the potential of HIF-1a as a predictive
marker for preeclampsia bearing in mind its expression and
morphological effects in ischemic environments and in
other neoplastic scenarios. The role of HIF-1a in the path-
ogenesis of preeclampsia and whether this transcription
factor can function as a marker for preeclampsia are still
being investigated. In preeclampsia, the transcription fac-
tor HIF-1a is reported to be best characterized in placental
trophoblasts,13,17 which was also consistently evident in our
study.
The use of 4-mm shaved en face sections of the
placental base afforded a greater yield of spiral arterioles
as compared with traditional longitudinal sections, because
the latter did not reflect as much surface area of thend well-vascularized placental villi rimmed by cytotrophoblasts
atherosis is noted. (B) Decidua showing the cross section of
inoid necrosis indicative of ongoing atherosis (hematoxylin and
Figure 2 (A) Intervillous erythrocytes are seen to stain strongly to hypoxia-inducible factor-1a (HIF-1a) but not the cyto-
trophoblasts and syncytiotrophoblasts in placentae without preeclampsia. (B) Cytotrophoblasts and syncytiotrophoblasts are seen
to uniformly demonstrate strong positivity for HIF-1a in all the cases of preeclampsia.
124 M. Akhilesh et al.fetoematernal interface. However, this study does not
conclude with confidence that the shaved sections can
replace myometrial biopsies (placental bed). The confir-
mation of placental ischemia by histomorphological and
immunohistochemical studies was successful to a large
extent due to the use of shaved en face sections of the
placental base that gave a significantly greater yield of
spiral arterioles. This finding correlated with the observa-
tions of other authors who suggested that shaved sections
of the placental base were equivalent to bed biopsies in the
assessment of arteriole morphology.6,8,18 A dedicated study
to compare spiral arteriole populations demonstrable in
both types of biopsy could be one of the future directions
that could aid in the better understanding of fetoemater-
nal vasculature and its related problems, whether
anatomical or thrombogenic.
Atherosis, in addition to fibrinoid degeneration of blood
vessel walls, also includes the presence of foamy/clear
cells within the vascular lumina.19 The propensity of the
HIF-1a to duplicate the morphological evidence of pro-
ducing clear cells in several scenarios propelled the hy-
pothesis that HIF-1a is likely to be expressed by
cytotrophoblasts in a hypoxic environment. During its
presence in ischemic environments, it is expressed as a
transcription factor and additionally leaves the evidence of
its existence in the form of clear cells (atherosis).15,20
Elevated levels and expression of HIF-1a in mothers with
preeclampsia did not impact the placental weights directly,
which can be interpreted as the mothers with the highest
levels of the transcription factor did not exhibit the lowest
placental weights. Again, this finding suggests that the
transcription factor reflects an ischemic environment
and does not contribute to the pathogenesis of the
consequences of aberrant pseudovasculogenesis such as
reduced placental weights and intrauterine growth
restriction.15,18,19
Aberrant pseudovasculogenesis and the subsequent
placental ischemia is a consistent feature of placentae of
mothers manifesting with preeclampsia. As discussed by
other authors,17e19 infarction and syncytial knots were a
common feature in placentae of mothers with preeclamp-
sia, and this was duplicated in all cases of preeclampsia in
this study. The other consistent feature indicative of
placental ischemia was increased syncytial knots. The
manifestation of geographic placental villi was alsodescribed by some authors, as accelerated maturation was
again noted to be a consistent feature of ischemia in
placentae of mothers with preeclampsia.15,18,19
The expression of HIF-1a by the nuclei of all cyto-
trophoblastic cells in the placental villi of mothers with
preeclampsia suggests that there is an overexpression of
HIF-1a in hypoxic placentae. This finding was supported by
the histologic correlates of placental ischemia in the pre-
sent study and the increased levels of HIF-1a in prenatal
blood samples of mothers with preeclampsia.20e22
The expression of HIF-1a by cytotrophoblasts and its
association with elevated blood levels of HIF-1a in mothers
with preeclampsia20,21 suggest that the cytotrophoblasts
reflect and contribute to the ischemic environment. HIF-1a
distribution was uniform within all cytotrophoblastic cells
with a strong nuclear accentuation, which suggests a
consistent expression of this transcription factor within
these cells in preeclampsia. It could be an indirect indicator
of absence of blood vessel wall invasion (aberrant pseudo-
vasculogenesis) creating an ischemic environment that
leads to the expression of HIF-1a within cytotrophoblastic
cell nuclei.21,22
The identification of HIF-1a within the cytotropho-
blastic cell nuclei confirms the expression of this tran-
scription factor within cells that are stipulated to play the
most important role in instituting successful placentation
but have failed to achieve this in preeclampsia. This in-
dicates that cytotrophoblasts respond to and reflect an
ischemic environment by their nuclear expression of HIF-
1a, which suggests that this transcription factor has great
potential to be further investigated as a blood marker for
preeclampsia.
A previous study suggested that pre- and postnatal blood
samples of normal mothers showed baseline levels of the
transcription factor.23 Although this does suggest that
pregnancy as a physiological stressful condition could by
itself induce a minor degree of ischemia in all mothers, it
could also suggest that the future direction of trying to
establish the credibility of HIF-1a as a predictive marker in
preeclampsia requires the measurement of this transcrip-
tion factor in nonpregnant women of similar age groups.
In conclusion, HIF-1a shows great potential of being a
consistent and reliable predictive blood marker for pre-
eclampsia. It opens up greater opportunities for further
research on the topic across races and population groups.
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